BR112013016231A2 - resposta imune aumentada em espécies bovinas - Google Patents
resposta imune aumentada em espécies bovinasInfo
- Publication number
- BR112013016231A2 BR112013016231A2 BR112013016231A BR112013016231A BR112013016231A2 BR 112013016231 A2 BR112013016231 A2 BR 112013016231A2 BR 112013016231 A BR112013016231 A BR 112013016231A BR 112013016231 A BR112013016231 A BR 112013016231A BR 112013016231 A2 BR112013016231 A2 BR 112013016231A2
- Authority
- BR
- Brazil
- Prior art keywords
- immune response
- increased immune
- bovine species
- bovine
- species
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426255P | 2010-12-22 | 2010-12-22 | |
| US61/426,255 | 2010-12-22 | ||
| PCT/EP2011/073414 WO2012084951A1 (en) | 2010-12-22 | 2011-12-20 | Enhanced immune response in bovine species |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013016231A2 true BR112013016231A2 (pt) | 2016-09-27 |
| BR112013016231B1 BR112013016231B1 (pt) | 2021-03-23 |
Family
ID=45444595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013016231-7A BR112013016231B1 (pt) | 2010-12-22 | 2011-12-20 | Composição imunomoduladora para o tratamento de doença respiratória bovina |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US20130295167A1 (pt) |
| EP (1) | EP2654785B1 (pt) |
| JP (2) | JP6058550B2 (pt) |
| KR (1) | KR101940826B1 (pt) |
| CN (2) | CN103501810A (pt) |
| AR (1) | AR084510A1 (pt) |
| AU (1) | AU2011347464B2 (pt) |
| BR (1) | BR112013016231B1 (pt) |
| CA (1) | CA2822359C (pt) |
| CL (1) | CL2013001833A1 (pt) |
| CO (1) | CO6761354A2 (pt) |
| CR (1) | CR20130312A (pt) |
| DK (1) | DK2654785T3 (pt) |
| DO (1) | DOP2013000149A (pt) |
| EC (1) | ECSP13012709A (pt) |
| ES (1) | ES2722204T3 (pt) |
| GT (1) | GT201300168A (pt) |
| HK (1) | HK1259341A1 (pt) |
| HR (1) | HRP20190779T1 (pt) |
| HU (1) | HUE043473T4 (pt) |
| IL (1) | IL226733B (pt) |
| LT (1) | LT2654785T (pt) |
| MX (1) | MX345854B (pt) |
| MY (1) | MY167159A (pt) |
| NZ (1) | NZ612285A (pt) |
| PL (1) | PL2654785T3 (pt) |
| PT (1) | PT2654785T (pt) |
| RU (1) | RU2606855C2 (pt) |
| SI (1) | SI2654785T1 (pt) |
| TR (1) | TR201906323T4 (pt) |
| TW (1) | TWI587877B (pt) |
| UA (1) | UA118537C2 (pt) |
| UY (1) | UY33821A (pt) |
| WO (1) | WO2012084951A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012084951A1 (en) * | 2010-12-22 | 2012-06-28 | Bayer Animal Health Gmbh | Enhanced immune response in bovine species |
| JO3733B1 (ar) | 2011-04-05 | 2021-01-31 | Bayer Ip Gmbh | استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة |
| MX2016010993A (es) | 2014-02-28 | 2017-05-01 | Bayer Animal Health Gmbh | Plasmidos inmunoestimuladores. |
| CN104825393B (zh) * | 2015-01-16 | 2017-11-10 | 艾美科健（中国）生物医药有限公司 | 一种硫酸头孢喹肟肺靶向脂质体制剂及其制备方法 |
| AU2016282879A1 (en) * | 2015-06-26 | 2018-01-18 | Bayer Animal Health Gmbh | Methods of modulating cytosolic DNA surveillance molecules |
| SG10202000891UA (en) * | 2015-07-31 | 2020-03-30 | Bayer Animal Health Gmbh | Enhanced immune response in porcine species |
| DK3328423T3 (da) * | 2015-07-31 | 2021-07-26 | Bayer Animal Health Gmbh | Forbedret immunrespons hos fisk |
| BR112019001599A2 (pt) * | 2016-07-26 | 2019-10-01 | Bayer Animal Health Gmbh | fertilidade aumentada em espécies bovinas |
| KR102069670B1 (ko) * | 2017-03-02 | 2020-01-23 | 단디바이오사이언스 주식회사 | 면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물 |
| BR112020011845A2 (pt) * | 2017-12-15 | 2020-11-24 | Bayer Animal Health Gmbh | composições imunoestimulatórias |
| CN108812546A (zh) * | 2018-09-07 | 2018-11-16 | 四川省草原科学研究院 | 适于青藏高原地区牦牛运输减少应激的药物及使用方法 |
| CN109646435B (zh) * | 2019-01-11 | 2021-08-03 | 山东省农业科学院奶牛研究中心 | 厄他培南钠在制备防治牛传染性鼻气管炎药物中的应用 |
| WO2020194735A1 (ja) | 2019-03-28 | 2020-10-01 | 日本電気株式会社 | 情報処理装置、サーバ割当装置、方法、及びコンピュータ可読媒体 |
| CN114480663A (zh) * | 2021-11-15 | 2022-05-13 | 贵州省畜牧兽医研究所 | 用于检测猪源差异脲原体的引物对、试剂盒及检测方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5427791A (en) | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US5830878A (en) * | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
| US20030022854A1 (en) * | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20040247662A1 (en) * | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
| ATE549032T1 (de) | 1999-03-26 | 2012-03-15 | Vical Inc | Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen |
| RU2158587C1 (ru) * | 1999-05-11 | 2000-11-10 | Ставропольское научно-производственное объединение "Пульс" | Антибактериальное средство для лечения заболеваний сельскохозяйственных животных и птиц, способ профилактики и лечения цыплят при заболеваниях бактериальной этиологии, способ лечения респираторной болезни телят бактериальной этиологии, способ профилактики туберкулеза у крупного рогатого скота |
| US20040002472A1 (en) * | 2000-01-21 | 2004-01-01 | Audonnet Jean-Christophe Francis | Vaccination or immunization using a prime-boost regimen |
| PE20020572A1 (es) * | 2000-12-06 | 2002-07-31 | Centro Inmunologia Molecular | Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos |
| CA2443781A1 (en) | 2001-04-24 | 2002-10-31 | Innogenetics N.V. | Core-glycosylated hcv envelope proteins |
| EP1521592A2 (en) * | 2001-07-02 | 2005-04-13 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| PL1605971T3 (pl) * | 2003-03-26 | 2010-10-29 | Wyeth Llc | Kompozycja immunogenna i sposoby |
| TW200505425A (en) * | 2003-05-29 | 2005-02-16 | Schering Plough Ltd | Compositions and method for treating infection in cattle and swine |
| AU2004280143A1 (en) * | 2003-10-11 | 2005-04-21 | Tekmira Pharmaceuticals Corporation | Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| US20090068223A1 (en) | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| JP2008094763A (ja) * | 2006-10-12 | 2008-04-24 | Takeshi Ogura | 海洋ミネラル成分からなるインターフェロンγ産生増強剤 |
| EP2249843A4 (en) * | 2008-02-24 | 2013-05-08 | Us Gov Health & Human Serv | USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGENIC INFECTIONS |
| WO2009120811A1 (en) * | 2008-03-25 | 2009-10-01 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
| JP2012507537A (ja) * | 2008-10-31 | 2012-03-29 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | マイコプラズマ・ボビスの抗原を含む種々の抗原の多価ワクチン組成物における使用 |
| EP2429581B1 (en) * | 2009-05-14 | 2015-08-05 | Bayer Intellectual Property GmbH | Enhanced immune response in avian species |
| WO2012084951A1 (en) * | 2010-12-22 | 2012-06-28 | Bayer Animal Health Gmbh | Enhanced immune response in bovine species |
-
2011
- 2011-12-20 WO PCT/EP2011/073414 patent/WO2012084951A1/en active Application Filing
- 2011-12-20 PT PT11804675T patent/PT2654785T/pt unknown
- 2011-12-20 MX MX2013007064A patent/MX345854B/es active IP Right Grant
- 2011-12-20 NZ NZ612285A patent/NZ612285A/en unknown
- 2011-12-20 UY UY0001033821A patent/UY33821A/es not_active Application Discontinuation
- 2011-12-20 RU RU2013133730A patent/RU2606855C2/ru active
- 2011-12-20 US US13/995,960 patent/US20130295167A1/en not_active Abandoned
- 2011-12-20 EP EP11804675.4A patent/EP2654785B1/en active Active
- 2011-12-20 TR TR2019/06323T patent/TR201906323T4/tr unknown
- 2011-12-20 HU HUE11804675A patent/HUE043473T4/hu unknown
- 2011-12-20 KR KR1020137018801A patent/KR101940826B1/ko active IP Right Grant
- 2011-12-20 UA UAA201308922A patent/UA118537C2/uk unknown
- 2011-12-20 BR BR112013016231-7A patent/BR112013016231B1/pt active IP Right Grant
- 2011-12-20 SI SI201131729T patent/SI2654785T1/sl unknown
- 2011-12-20 CA CA2822359A patent/CA2822359C/en active Active
- 2011-12-20 CN CN201180066905.3A patent/CN103501810A/zh active Pending
- 2011-12-20 LT LTEP11804675.4T patent/LT2654785T/lt unknown
- 2011-12-20 MY MYPI2013701066A patent/MY167159A/en unknown
- 2011-12-20 DK DK11804675.4T patent/DK2654785T3/da active
- 2011-12-20 ES ES11804675T patent/ES2722204T3/es active Active
- 2011-12-20 CN CN201810200992.0A patent/CN108379576A/zh active Pending
- 2011-12-20 JP JP2013545307A patent/JP6058550B2/ja active Active
- 2011-12-20 AU AU2011347464A patent/AU2011347464B2/en active Active
- 2011-12-20 PL PL11804675T patent/PL2654785T3/pl unknown
- 2011-12-21 AR ARP110104848A patent/AR084510A1/es unknown
- 2011-12-21 TW TW100147617A patent/TWI587877B/zh active
-
2013
- 2013-06-04 IL IL226733A patent/IL226733B/en active IP Right Grant
- 2013-06-20 CL CL2013001833A patent/CL2013001833A1/es unknown
- 2013-06-21 DO DO2013000149A patent/DOP2013000149A/es unknown
- 2013-06-21 GT GT201300168A patent/GT201300168A/es unknown
- 2013-06-21 CO CO13148228A patent/CO6761354A2/es not_active Application Discontinuation
- 2013-06-21 EC ECSP13012709 patent/ECSP13012709A/es unknown
- 2013-06-21 US US13/923,496 patent/US20140010865A1/en not_active Abandoned
- 2013-06-21 CR CR20130312A patent/CR20130312A/es unknown
-
2016
- 2016-09-12 JP JP2016177599A patent/JP2017036290A/ja active Pending
-
2018
- 2018-08-08 US US16/058,888 patent/US10751361B2/en active Active
-
2019
- 2019-01-31 HK HK19101707.1A patent/HK1259341A1/zh unknown
- 2019-04-25 HR HRP20190779TT patent/HRP20190779T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013016231A2 (pt) | resposta imune aumentada em espécies bovinas | |
| BR112015008118A2 (pt) | reforço da resposta imune | |
| BR112013001592A2 (pt) | artigo e método | |
| DK2756080T3 (da) | Multimeriske oligonukleotidforbindelser | |
| BR302013001737S1 (pt) | Configuração aplicada em mobiliário | |
| DK2992899T3 (da) | Forøget immunrespons hos fuglearter | |
| DK2812356T3 (da) | CDIM-bindende proteiner og anvendelser deraf | |
| BR112013010847A2 (pt) | artigo e método | |
| BR302012006020S1 (pt) | Configuração aplicada em mobiliário | |
| BR302013001716S1 (pt) | Configuração aplicada em mobiliário | |
| DK2920208T3 (da) | Rekombinante celleoverflade-capture-proteiner | |
| CO6870003A2 (es) | Vacunas bovinas y métodos | |
| PT2665818T (pt) | Expressão de proteínas em plantas | |
| DK2721152T3 (da) | Dimere bindingsproteiner baseret på modificerede ubiquitiner | |
| BR112013016641A2 (pt) | artigo e método | |
| BR302013001712S1 (pt) | Configuração aplicada em mobiliário | |
| DK2704744T3 (da) | Komplementfaktor-b-analoger og anvendelser deraf | |
| BR302013001714S1 (pt) | Configuração aplicada em mobiliário | |
| DK2672837T4 (da) | Ernæringssammensætning og anvendelser deraf | |
| BR302013001439S1 (pt) | Configuração aplicada em mobiliário | |
| BR302012003637S1 (pt) | Configuração ornamental em cepo | |
| BRDI7103715S (pt) | Configuração aplicada em confeito | |
| BRDI7105248S (pt) | Configuração aplicada em andador | |
| BR302012006452S1 (pt) | Configuração ornamental em briquedo | |
| UY3960Q (es) | Configuración aplicada en licuadora |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/711 (2006.01), A61K 9/00 (2006.01), A61K 9 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2011, OBSERVADAS AS CONDICOES LEGAIS. |